Digital
23rd -24th September 2021

MarketsandMarkets Advanced Genetic Sequencing Virtual Conference [Time zone- Eastern Standard Time (EST)]

Nanopore sequencing and its application to pandemic epidemiological survey of SARS CoV-19 and strains surveillance. Now, with COVID therapeutic manufacturing taking priority, there is a big desire to accelerate other clinical pipeline because of ample opportunity for new medicine.

MarketsandMarkets is proud to announce the Advanced Genetic Sequencing Virtual Conference scheduled to be held on 23-24 September 2021 will hold discussions on trending technologies and its applications, challenges of implying these technologies into clinical specimen, practice of sequencing in healthcare domain specifically to cancer cells, overview of the data used in these technologies and its applications. This event will witness an overwhelming participation of leading healthcare and industry decision makers.

MarketsandMarkets is proud to announce the Advanced Genetic Sequencing Virtual Conference scheduled to be held on 23-24 September presents to you a virtual platform to keep your scientific exchange live. It will hold discussions on trending technologies of sequencing and its applications, challenges of implying these technologies into clinical specimen, practice of sequencing in healthcare domain specifically to cancer cells, overview of the data used in these technologies and its applications. This event will witness an overwhelming participation of leading healthcare and industry decision makers.

WHAT TO EXPECT

Key Highlights

  • Short Read Sequencing & Long Read Sequencing – Single cell Analysis 
  • Human disease – Virus interacts with DNA and how sequencing helps in it. 
  • Spatial sequencing and its applications 
  • What’s new in Nano pore sequencing technology. Applications of Nano pore sequencing in healthcare 
  • Nano pore sequencing to pandemic epidemiology survey of Covid-19 and strain surveillance 
  • A multipanel IS and its uses in IHC

Why Attend?

  • Learn about the recent trends and advancements occurring in Sequencing market.
  • Engage in meaningful discussion with the most prominent industry experts and decision makers from pharmaceutical manufactures, therapeutic companies and Healthcare who will address most critical challenges in different sequencing process.
  • Opportunity to network and exchange scientific knowledge with expert speakers from leading manufacturers, global regulators, and solution providers

 

Who Should Attend?

Professionals in Healthcare, Therapeutics, Universities/ Pharmaceuticals:

  • C-Level
  • Vice Presidents
  • Presidents
  • Senior Directors
  • Directors
  • Global Heads
  • Heads
  • Managers

Working in departments of Bioinformatics, Genomics, Molecular Biology, Oncology, Biotechnology and Biochemistry

CONFERENCE AGENDA
CONFERENCE SPEAKERS
Advisors
Matt Davis
Matt Davis
Director, Molecular biology and Sequencing, Gritstone Oncology, Inc.
Speakers
Dr. Catia Moutinho
Dr. Catia Moutinho
Group Leader Single Cell Technology Development, GWCCG, Australia
Wei Vivian
Wei Vivian
Assistant Professor, Rutgers School of Public Health
Ning Wang
Ning Wang
Bioinformatics Lead, Arcus Biosciences
Grace Zhao
Grace Zhao
Co- Founder, Avida Biomed
Bhagya Wijayawardena
Bhagya Wijayawardena
Global Commercial Product Manager, Beckman Coulter
Shrikant Mane
Shrikant Mane
Executive Director, Yale Center for Genome Analysis (YCGA)
Seth Crosby
Seth Crosby
Director, Research Collaborations, Washington University School of Medicine
Matt Davis
Matt Davis
Director, Molecular biology and Sequencing, Gritstone Oncology, Inc.
SPONSORS
Platinium
example-image

Beckman Coulter

PARTNERS
Media Partners
example-image

PharmaTutor

example-image

Pharma Journalist

example-image

This Week in Digital Health

PAST EVENT GALLERY